SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Novo Nordisk A/S is a global healthcare company, which engages in the discovery, development, manufacturing and marketing of pharmaceutical products. It operates through the Diabetes and Obesity Care and Rare Disease segments. The Diabetes and Obesity Care segment includes diabetes, obesity, cardiovascular, and emerging therapy areas. The Rare Disease segment refers to rare blood disorders, rare endocrine disorders, and hormone replacement therapy. The company was founded by Harald Pedersen and Thorvald Pedersen in 1923 is headquartered in Bagsværd, Denmark.

Novo Nordisk - ADR

Novo Nordisk A/S

Novo Nordisk is seeing significant market reaction after its next-generation obesity drug, CagriSema, demonstrated slightly less weight loss than Eli Lilly's Zepbound in a pivotal trial, failing to meet its primary endpoint. While this is driving a sharp sell-off and competitive concerns, many in the community highlight the strong uptake and superior efficacy of Novo's oral Wegovy pill, leading to strong dip-buying interest on perceived overreaction.

CrowdStrike Holdings, Inc. provides cybersecurity products and services to stop breaches. It offers cloud-delivered protection across endpoints, cloud workloads, identity and data, and threat intelligence, managed security services, IT operations management, threat hunting, Zero Trust identity protection, and log management. CrowdStrike serves customers worldwide. The company was founded by George P. Kurtz, Gregg Marston, and Dmitri Alperovitch on November 7, 2011 and is headquartered in Austin, TX.

Crowdstrike Holdings Inc - Ordinary Shares - Class A

Crowdstrike Holdings Inc

Crowdstrike faces intense selling pressure amidst broader cybersecurity sector concerns, driven by market fears that new AI tools, like Anthropic's offering, threaten traditional security platforms. However, many in the community contend that these fears are overblown, asserting that AI will enhance, not replace, CrowdStrike's established AI-native endpoint and cloud protection.

ImmunityBio, Inc. is a clinical stage immunotherapy company. It develops next generation therapies that drive immunogenic mechanisms for defeating cancers and infectious diseases. The company's immunotherapy platform activates both the innate and adaptive immune systems to create long term immunological memory. ImmunityBio was founded by Patrick Soon-Shiong in 2014 and is headquartered in San Diego, CA.

ImmunityBio Inc

ImmunityBio (IBRX) is surging following robust Q4 revenue growth driven by its ANKTIVA immunotherapy, fueling widespread community discussion about a potential short squeeze and significant global expansion for its cancer treatments.

Vanda Pharmaceuticals, Inc. engages in the development and commercialization of therapies for high unmet medical needs. The firm intends to treat schizophrenia, jet lag disorder, atopic dermatitis, central nervous system disorders, and circadian rhythm sleep disorder. Its product portfolio includes HETLIOZ, Fanapt, NEREUS, Ponvory, and HETLIOZAccess. The company was founded by Mihael Hristos Polymeropoulos and Argeris N. Karabelas in 2002 and is headquartered in Washington, DC.

Vanda Pharmaceuticals Inc

Vanda Pharmaceuticals is trending following its recent FDA approval of BYSANTI, a new chemical entity with patent protection extending to 2044, for treating bipolar I disorder and schizophrenia. The community is actively discussing the company's significant undervaluation compared to prior rejected acquisition offers, anticipating a substantial re-rating and potential further upside driven by its robust pipeline and the long-term revenue potential of its approved drugs.

BlackRock Institutional Trust Company N.A. - iShares Expanded Tech-Software Sector ETF

iShares Expanded Tech-Software Sector ETF

The iShares Expanded Tech-Software Sector ETF is trending amidst an intense debate over whether AI innovations, notably from Anthropic's Claude, signal an "AI apocalypse" for traditional SaaS, or if the severe sell-off represents a capitulation-driven buying opportunity. Despite record short interest and concerns over disruption, many argue the sector is technically oversold and fundamentally resilient against the perceived threat.

Lucid Group, Inc. manufactures electric vehicles. It designs, develops, and builds energy storage systems for electric vehicles and supplies automakers with the battery pack system needed to power hybrid, plug-in, and electric vehicles. The company was founded in December 2007 and is headquartered in Newark, CA.

Lucid Group Inc

Lucid Group is trending as recent layoffs and a persistent decline to new all-time lows intensify bearish sentiment with its upcoming Q4 earnings report in focus, triggering widespread calls to fire management and heightening fears of further dilution among the community.

Salesforce, Inc. engages in the design and development of cloud-based enterprise software for customer relationship management. Its solutions include sales force automation, customer service and support, marketing automation, digital commerce, community management, collaboration, industry-specific solutions, and salesforce platform. The firm also provides guidance, support, training, and advisory services. The company was founded by Marc Russell Benioff and Parker Harris in 1999 and is headquartered in San Francisco, CA.

Salesforce Inc

Salesforce is driving intense debate ahead of its upcoming Q4 earnings, as investors are sharply divided between those aggressively buying the stock as deeply undervalued amidst AI disruption fears and those remaining bearish, citing continued analyst downgrades across the software sector.

SSgA Active Trust - State Street SPDR S&P 500 ETF Trust

SPY is experiencing a notable downturn, primarily driven by community reactions to renewed tariff uncertainty and escalating geopolitical concerns, sparking intense debate among traders regarding the possibility of a "V-shaped" recovery versus a deeper market "flush."

Zscaler, Inc. engages in the provision of a cloud-based internet security platform. It offers Zero Trust Exchange, Zscaler Client Connector, Zscaler Internet Access, Zscaler Private Access, Zscaler B2B, Zscaler Cloud Protection, and Zscaler Digital Experience. The company was founded by Jagtar Singh Chaudhry and K. Kailash in September 2007 and is headquartered in San Jose, CA.

Zscaler Inc

Zscaler is trending amid intense debate over whether AI advancements, like Claude Code Security, pose an existential threat to cybersecurity firms or enhance the need for their solutions. While many express panic and delisting fears following recent sell-offs, a significant portion of the community sees an oversold buying opportunity, arguing that Zscaler's zero-trust architecture is essential for navigating an AI-driven threat landscape.

JPMorgan Chase & Co. is a financial holding company, which engages in the provision of financial and investment banking services. It focuses on investment banking, financial services for consumers and small businesses, commercial banking, financial transaction processing, and asset management. It operates through the following segments: Consumer and Community Banking (CCB), Commercial and Investment Bank (CIB), Asset and Wealth Management (AWM), and Corporate. The CCB segment originates and services mortgage loans. The CIB segment makes markets and services clients across fixed income, foreign exchange, equities, and commodities. The AWM segment provides initial capital investments in products such as mutual funds and capital invested alongside third-party investors. The Corporate segment manages its liquidity, funding, capital, structural interest rate, and foreign exchange risks. The company was founded in 1799 and is headquartered in New York, NY.

JPMorgan Chase & Co.

JPMorgan Chase & Co

JPMorgan Chase is a major talking point due to a prominent lawsuit alleging political debanking, alongside recent regulatory fines that fuel broader community discussions around the financial sector's stability and market integrity.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Scotia: We remain positive on the large Canadian banks heading into Q1 earnings season that we suspect will once again feature strong results in market-sensitive businesses, upside to all-bank margins that will help keep NII growing despite only modest loan volumes, &amp; credit losses remaining in a very manageable range in the absence of any signs of meaningful deterioration in the economic outlook 
 
With those dynamics, we see a strong possibility that results could in fact come in ahead of our current expectations/consensus &amp; drive further upside revisions to EPS ests, which we believe will be key to share price upside potential for the group in the near-term. 
 
Large banks traded at a market cap-weighted fwd P/E multiple of 12.7x on FY27 consensus EPS, which is well above the group’s historical average of 11.1x...we don’t foresee the likelihood of multiple expansion in the near-term, which means that any upside will need to be driven by upward revisions to EPS ests 
 
$TD $RY $BNS $BMO $CM

StockTwits Web

Toronto Dominion Bank

Royal Bank Of Canada

Bank Of Nova Scotia

Bank of Montreal

Canadian Imperial Bank Of Commerce

Scotia: We remain positive on the large Canadian banks heading into Q1 earnings season that we suspect will once again feature strong results in market-sensitive businesses, upside to all-bank margins that will help keep NII growing despite only modest loan volumes, & credit losses remaining in a very manageable range in the absence of any signs of meaningful deterioration in the economic outlook 
 
With those dynamics, we see a strong possibility that results could in fact come in ahead of our current expectations/consensus & drive further upside revisions to EPS ests, which we believe will be key to share price upside potential for the group in the near-term. 
 
Large banks traded at a market cap-weighted fwd P/E multiple of 12.7x on FY27 consensus EPS, which is well above the group’s historical average of 11.1x...we don’t foresee the likelihood of multiple expansion in the near-term, which means that any upside will need to be driven by upward revisions to EPS ests 
 
